Email this article Bowel Diseases and Kidneys
Abstract
This review of contemporary publications analyzes the prevalence of combinations of bowel and renal diseases. Special attention is paid to the problem of correlation between bowel diseases and urolithiasis. We consider the possible pathogenic mechanisms of lesions, such as genetically determined violations of intestinal absorption and secretion, changes in the intestinal microbiota, systemic inflammatory response, water and electrolyte disturbances.
Keywords
Full Text:
PDF (Русский)References
Burisch J. The epidemiology of inflammatory bowel disease / J. Burisch, P. Munkholm // Scand. J. Gastroenterol. — 2015, Feb 17. — Р. 1-10 [Epub ahead of print].
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens / K. Kiryluk, Y. Li, F. Scolari [et al.] // Nat. Genet. — 2014, Nov. — № 46(11). — Р. 1187-96.
Yin K. Vitamin D and inflammatory diseases / K. Yin, D.K. Agrawal // J. Inflamm. Res. — 2014, May 29. — № 7. — Р. 69-87.
Renal manifestations and complications of inflammatory bowel disease / К. Oikonomou, A. Kapsoritakis, T. Eleftheriadis [et al.] // Inflamm. Bowel Dis. — 2011, Apr. — № 17(4). — Р. 1034-45.
Baldwin D.N. Carbohydrate intolerance and kidney stones in children in the Goldfields / D.N. Baldwin, J.L. Spencer, C.A. Jeffries-Stokes // J. Paediatr. Child Health. — 2003, Jul. — № 39(5). — Р. 381-5.
Helvaci M.R. Irritable bowel syndrome and chronic gastritis, hemorrhoid, urolithiasis / M.R. Helvaci, M.C. Algin, H. Kaya // Eurasian J. Med. — 2009, Dec. — № 41(3). — Р. 158-61.
Celiac disease in children with urolithiasis / E. Menekşe, M.A. Selimoğlu, I. Temel [et al.] // Turk. J. Pediatr. — 2012, Jul-Aug. — № 54(4). — Р. 382-6.
Cholelithiasis and urolithiasis in Crohn’s disease / H. Andersson, I. Bosaeus, S. Fasth [et al.] // Scand. J. Gastroenterol. — 1987, Mar. — № 22(2). — Р. 253-6.
Renal and urolog complications of inflammatory bowel disease / D.S. Pardi, W.J. Tremaine, W.J. Sandborn, J.T. McCarthy // Am. J. Gastroenterol. — 1998. — № 93. — Р. 504-514.
Nephrolithiasisin patients with intestinal diseases / M. Cirillo, M. Iudici, F. Marcarelli [et al.] // G. Ital. Nefrol. — 2008, Jan-Feb. — № 25(1). — Р. 42-8.
Bushinsky D.A., Coe F.L., Moe O.W. Nephrolithiasis // Brenner and Rector’s The Kidney. — 8th ed. — Saunders, 2007.
Liebman M. Probiotics and other key determinants of dietary oxalate absorption / M. Liebman, I.A. Al-Wahsh // Adv. Nutr. — 2011, May. — № 2(3). — Р. 254-60.
The role of Oxalobacter formigenes colonization in calcium oxalate stone disease / R. Siener, U. Bangen, H. Sidhu [et al.] // Kidney Int.— 2013, Jun. — № 83(6). — Р. 1144-9.
Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery / R. Kumar, J.C. Lieske, M.L. Collazo-Clavell [et al.] // Surgery. — 2011, May. — № 149(5). — Р. 654-61.
Ferraz R.R. Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion / R.R. Ferraz, H.G. Tiselius, I.P. Heilberg // Kidney Int. — 2004, Aug. — № 66(2). — Р. 676-82.
Torzewska A. Oxalobacter formigenes-characteristics and role in development of calcium oxalate urolithiasis / A. Torzewska // Postepy Hig. Med. Dosw. (Online). — 2013, Nov 27. — № 67. — Р. 1144-53.
Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion / M. Hatch, J. Cornelius, M. Allison [et al.] // Kidney Int. — 2006. — № 69. — Р. 691-698.
Siener R., Bangen U., Sidhu H. et al. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease // Kidney Int. — 2013, Jun. — № 83(6). — Р. 1144-9.
The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease / J. Knight, R. Deora, D.G. Assimos, R.P. Holmes // Urolithiasis. — 2013, Jun. — № 41(3). — Р. 187-96.
Infrequency of colonization with Oxalobacter for migenesin inflammatory bowel disease: possible role in renal stone formation / R. Kumar, U.C. Ghoshal, G. Singh, R.D. Mittal // J. Gastroenterol. Hepatol. — 2004, Dec. — № 19(12). — Р. 1403-9.
A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease / S. Siva, E.R. Barrack, G.P. Reddy [et al.] // BJU Int. — 2009, Jan. — № 103(1). — Р. 18-21.
Evaluating Children in the Ukraine for Colonization With the Intestinal Bacterium Oxalobacter for migenes, Using a Polymerase Chain Reaction-based Detection System / H. Sidhu, L. Enatska, S. Ogden [et al.] // Mol. Diagn. — 1997, Jun. — № 2(2). — Р. 89-97.
Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract / R.D. Mittal, R. Kumar, H.K. Bid, B. Mittal // J. Endourol. — 2005, Jan-Feb. — № 19(1). — Р. 102-6.
Liebman M. Probiotics and other key determinants of dietary oxalate absorption / M. Liebman, I.A. Al-Wahsh // Adv. Nutr. — 2011, May. — № 2(3). — Р. 254-60.
Oxalobacter formigenes: Opening the door to probiotic the-rapy for the treatment of hyperoxaluria / A. Jairath, N. Parekh, N. Otano [et al.] // Scand. J. Urol. — 2015, Feb 2. — Р. 1-4 [Epub ahead of print].
In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria / S. Giardina, C. Scilironi, A. Michelotti [et al.] // J. Food Sci. — 2014, Mar. — № 79(3). — M384-90.
Cury D.B. Nephrolithiasisin patients with inflammatory bowel disease in the community / D.B. Cury, A.C. Moss, N. Schor // Int. J. Nephrol. Renovasc. Dis. — 2013, Jul 29. — № 6. — Р. 139-42.
Moran M.E. Associated Systemic Diseases. Bowel and Bones / Stoller M.L., Meng M.V. // Urinary Stone Disease. — 2007, Humana Press Inc.
Renal insufficiency inIBD-prevalence and possible pathogenetic aspects / C. Primas, G. Novacek, K. Schweiger [et al.] // J. Crohn’s Colitis. — 2013, Dec 15. — № 7(12). — e630-4.
Risk factors for nephrolithiasis in patients with ileal pouches / S. Mukewar, P. Hall, B.A. Lashner [et al.] // J. Crohn’s Colitis. — 2013, Feb. — № 7(1). — Р. 70-8.
Stress-related alteration of urine compositions: idiopathic CaOx stone formers, patients with chronic inflammatory bowel disease (CIBD) and healthy controls / W. Berg, C. Uhlemann, A. Meissner, N. Laube // Urologe A. — 2011, Dec. — № 50(12). — Р. 1606-13.
The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn’s disease / J. Glas, J. Seiderer, C. Bayrle [et al.] // PLoS One. — 2011. — № 6(12). — e29309.
Inflammatory bowel disease: clinical aspects and treatments / M. Fakhoury, R. Negrulj, A. Mooranian, H. Al-Salami // J. Inflamm. Res. — 2014, Jun 23. — № 7. — Р. 113-20.
Bone marrow Th17 TNF-α cells induce osteoclast differentiation, and link bone destruction to IBD / T. Ciucci, L. Ibáñez, A. Boucoiran [et al.] // Gut. — 2014, Oct 8. — Рii: gutjnl-2014-306947 [Epub ahead of print].
Dietary calcium intake in patients with inflammatory bowel disease / P. Vernia, P. Loizos, I. Di Giuseppantonio [et al.] // J. Crohn’s Colitis. — 2014, Apr 1. — № 8(4). — Р. 312-7.
Wiederkehr M.R. Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder / M.R. Wiederkehr, O.W. Moe // Clin. Rev. Bone Miner. Metab. — 2011, Dec. — № 9(3–4). — Р. 207-217.
Sakhaee K. Epidemiology and clinical pathophysiology of uric acid kidney stones / K. Sakhaee // J. Nephrol. — 2014, Jun. — № 27(3). — Р. 241-5.
Metabolic syndrome frequency in inflammatory bowel diseases / E. Yorulmaz, G. Adali, H. Yorulmaz [et al.] // Saudi
J. Gastroenterol. — 2011 Nov-Dec. — № 17(6). — Р. 376-82.
Clinical study of ammonium acid urate urolithiasis / Y.H. Chou, C.N. Huang, W.M. Li [et al.] // Kaohsiung J. Med. Sci. — 2012, May. — № 28(5). — Р. 259-64.
Clinical evaluation of urolithiasis in Crohn’s disease / G. Ishii, K. Nakajima, N. Tanaka [et al.] // Int. J. Urol. — 2009, May. — № 16(5). — Р. 477-80.
DOI: https://doi.org/10.22141/2308-2097.3.57.2015.81532
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 GASTROENTEROLOGY
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2017
